{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T10:30:50Z","timestamp":1787135450638,"version":"build-2736575974"},"reference-count":20,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ocular Pharmacology and Therapeutics"],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:p>\n                    This study aimed to develop a porcine eye model used to predict corneal endothelial cell loss (ECL) associated with anterior chamber paracentesis (ACP) in a healthy adult human cornea. To assess the average wound area and ECL created by needle punctures, a 27-gauge (27G) needle was inserted at the limbus of a porcine eye through the clear cornea and into the anterior chamber. Needle-punctured areas were immediately collected, stained, and photographed with a digital light microscope. The wound areas were quantified in square millimeters (mm\n                    <jats:sup>2<\/jats:sup>\n                    ) and then extrapolated to predict ECL in a healthy adult human cornea. The average wound area of the puncture sites was 0.274 \u00b1 0.122 mm\n                    <jats:sup>2<\/jats:sup>\n                    . The needle punctures created a larger area of ECL than the observed cross-sectional area of the needle (0.12 mm\n                    <jats:sup>2<\/jats:sup>\n                    ). Extrapolating these data to the ECL that would occur in healthy adult human corneas, each 27G corneal needle puncture would damage 685 cells, or 0.21% of the corneal endothelial cell layer. The predicted wound areas for 28G, 30G, and 33G needles were 0.234 mm\n                    <jats:sup>2<\/jats:sup>\n                    , 0.163 mm\n                    <jats:sup>2<\/jats:sup>\n                    , and 0.072 mm\n                    <jats:sup>2<\/jats:sup>\n                    , respectively. The predicted cell loss for a 28G, 30G, and 33G needle stick corresponded to a loss of 586 cells (0.18% of the corneal endothelium), 407 cells (0.13% of the corneal endothelium), and 181 cells (0.06% of the corneal endothelium), respectively. Frequent ACPs following intravitreal injections may be associated with clinically significant ECL; thus, caution is advised, particularly in patients with compromised corneas and low endothelial cell counts.\n                  <\/jats:p>","DOI":"10.1177\/10807683251408349","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T16:12:46Z","timestamp":1767111166000},"page":"223-226","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Corneal Endothelial Cell Loss From Anterior Chamber Paracentesis in a Porcine Model"],"prefix":"10.1177","volume":"42","author":[{"given":"Ashley","family":"Nguyen","sequence":"first","affiliation":[{"name":"Allergan, an AbbVie, company, North Chicago, Illinois, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen B.","family":"Ramer","sequence":"additional","affiliation":[{"name":"Allergan, an AbbVie, company, North Chicago, Illinois, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Robinson","sequence":"additional","affiliation":[{"name":"Allergan, an AbbVie, company, North Chicago, Illinois, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjo.2013.04.012"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-019-0157-z"},{"key":"e_1_3_2_4_2","unstructured":"Pharmaceuticals A. IZERVAY (avacincaptad pegol intravitreal solution). 2023. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/217225s000lbl.pdf [Last accessed: August30 2024]."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-017-3702-1"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.65.12.815"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1995.01100060131047"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e31815892da"},{"key":"e_1_3_2_9_2","unstructured":"Co. A-TP Inc. Understanding Inner & Outer Needle Diameter. 2018. Available from: https:\/\/www.air-tite-shop.com\/Articles\/understanding-inner-and-outer-needle-diameter [Last accessed: August30 2024]."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e31824d0dda"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2010.297"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-023-00517-1"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2007.00939.x"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.13-13688"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2011.08.014"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1159\/000252983"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2022.03.015"},{"key":"e_1_3_2_18_2","first-page":"1153504","article-title":"Specular microscopic corneal endothelial cell changes following uneventful phacoemulsification in patients with gout","volume":"2022","author":"Abozaid M","unstructured":"Abozaid M, , Saad-Eldin R, , Farouk M, et al. Specular microscopic corneal endothelial cell changes following uneventful phacoemulsification in patients with gout. . J Ophthalmol 2022;2022:1153504.","journal-title":"J Ophthalmol"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1159\/000479437"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-020-0764-9"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-011-1617-9"}],"container-title":["Journal of Ocular Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10807683251408349","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10807683251408349","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10807683251408349","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T10:19:12Z","timestamp":1787134752000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10807683251408349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,5,1]]}},"alternative-id":["10.1177\/10807683251408349"],"URL":"https:\/\/doi.org\/10.1177\/10807683251408349","relation":{},"ISSN":["1080-7683","1557-7732"],"issn-type":[{"value":"1080-7683","type":"print"},{"value":"1557-7732","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]}}}